MG53在2型糖尿病患者中不标志心血管风险和全因死亡率:一项前性观察性研究
Cristina Bianchi1, Olga Vaccaro2, Mariarosaria Distaso3
1Department of Medical Specialties - Section of Metabolic Diseases and Diabetes, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Diabetes research and clinical practice
|September 25, 2023
概括
在2型糖尿病 (T2D) 中,MG53水平升高,但不能预测心血管风险或死亡率. 这项研究没有发现MG53与高加索T2D患者的长期结果之间的联系.
科学领域:
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
- 代谢综合征是代谢综合征的一种.
背景情况:
- 2型糖尿病 (T2D) 与显著的心血管发病率和死亡率有关.
- 胰岛素抵抗的标志物MG53在T2D中升高,并与β细胞功能障碍有关.
- MG53与T2D中心血管风险或死亡率之间的关联尚不清楚.
研究的目的:
- 调查循环MG53水平与心血管风险概况之间的关系.
- 确定MG53是否预测T2D的高加索人群全因死亡率.
- 将T2D患者的MG53水平与健康个体进行比较.
主要方法:
- 一项纵向研究涉及296名来自MIND.IT研究的高加索T2D参与者.
- 在基线测量血清MG53水平.
- 随访持续了17年,以评估心血管风险和全因死亡率.
主要成果:
- 与健康对照人群相比,T2D个体的MG53水平显著更高 (p < 0.001).
- 二型糖尿病女性的MG53水平高于二型糖尿病男性 (p = 0.001).
- MG53水平与HbA1c和静脉压相关,但不能预测死亡率.
结论:
- 循环中的MG53水平不作为高加索T2D个体心血管风险概况的标志物.
- MG53不能预测这个人群的长期全因死亡率.
- 可能需要进一步的研究来澄清MG53在T2D病理生理学中的作用.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Oral Hypoglycemic Agents: Biguanides and Glitazones
223
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
223
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
110
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
110
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Dipeptidyl Peptidase 4 Inhibitors
204
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
204


